Lanthanum Carbonate Tablets and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Lanthanum Carbonate Tablets and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanthanum carbonate
Brand name: Fosrenol
Synonyms: Lanthanum carbonate, Lanthanum
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanthanum Carbonate Tablets-Tilia Fe
- Lanthanum Carbonate Tablets-Tiludronate
- Lanthanum Carbonate Tablets-Timentin
- Lanthanum Carbonate Tablets-Timentin Add-Vantage
- Lanthanum Carbonate Tablets-Timentin Injection
- Lanthanum Carbonate Tablets-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Lanthanum Chewable Tablets
- Tildrakizumab-asmn Subcutaneous-Lanthanum Powder
- Tildrakizumab-asmn Subcutaneous-Lantus
- Tildrakizumab-asmn Subcutaneous-Lantus SoloStar
- Tildrakizumab-asmn Subcutaneous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)
- Tildrakizumab-asmn Subcutaneous-Lantus Solostar (Insulin Glargine (U-300) Pens)